| Similar Articles |
|---|
 |
The Motley Fool
April 13, 2009
Brian Orelli |
Prescriptions for Acquisitions Express Scripts announces that it is buying WellPoint's NextRx pharmaceutical benefit management subsidiaries for almost $4.7 billion.   |
The Motley Fool
July 30, 2009
Brian Orelli |
A Good Business Model for Bad Times Some businesses benefit when people are hurting. It's a beautiful time to be a pharmacy benefit manager, since that business model essentially results in them making more money when their customers save money. |
The Motley Fool
November 3, 2010
Brian Orelli |
A Generic Prescription for Double-Digit Growth MedcoHealth Solutions has it. |
The Motley Fool
August 31, 2011
Shubh Datta |
CVS Caremark Flattened by Higher Costs CVS Caremark profits remained relatively flat this quarter despite a substantial increase in revenue. |
The Motley Fool
February 25, 2009
Brian Orelli |
The Best Kind of Generic Growth Pharmacy benefit managers profit from penny-pinchers. |
The Motley Fool
July 25, 2011
Brian Orelli |
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion. |
The Motley Fool
April 29, 2010
Brian Orelli |
A Prescription to Investigate Further Let's not worry just yet about Medco's margins. |
The Motley Fool
August 16, 2010
Brian Orelli |
The Fine Line Between Saving Money and Making It Medco's trying to walk it. |
The Motley Fool
May 4, 2011
Jason Knapp |
Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will. |
The Motley Fool
November 4, 2009
Brian Orelli |
This One Is Thriving in a Recession Saving customers money makes it easy for Medco. |
The Motley Fool
March 22, 2010
Dave Mock |
A Big Upgrade for CVS Caremark This bullish call comes from more than just one analyst. |
The Motley Fool
March 22, 2010
Brian Orelli |
Health-Care Reform Passes! Here's Where to Invest Now Some healthy suggestions for your portfolio. |
The Motley Fool
August 1, 2008
Brian Orelli |
Express Scripts Gets More Generic Pharmacy benefits manager Express Scripts may not have grown the top line by much in the second quarter, but using more generic drugs had a positive effect on the bottom line. |
The Motley Fool
October 2, 2011
Shubh Datta |
Would You Invest in This Drug Retailer? Is CVS Caremark worth your investment? |
The Motley Fool
April 19, 2011
Bryan White |
Rising Star Buy: Medco Health Medco has a much brighter future than its current stock price implies. |
The Motley Fool
June 2, 2011
Dee Gill |
CVS's Improved Performance Begins to Drown Out the Dump-Caremark Chants Is the prognosis for CVS looking up? |
The Motley Fool
October 22, 2010
Roger Friedman |
3 Health-Care Stocks for Your Watchlist There's money to be made in health care. But finding the right plays, especially among health care providers, can prove confounding. |
The Motley Fool
June 30, 2011
David Williamson |
Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split. |
The Motley Fool
April 22, 2009
Brian Orelli |
UnitedHealth Rocks; Its Stock Doesn't With all the good news floating around, why is UnitedHealth still trading at 7.3 times the middle of this year's guidance? Alas, there's still plenty of uncertainty hanging over the company. |
The Motley Fool
February 27, 2009
Brian Orelli |
Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas. |
The Motley Fool
July 27, 2004
Brian Gorman |
Medco's Pumped About Generics Generic drugs are actually helping improve Medco's margins, making it a winner with investors and health-care plans. |
The Motley Fool
January 15, 2009
Brian Orelli |
A Clean Bill of Health in 2009 UnitedHealth settles a few lawsuits to start the new year. |
The Motley Fool
April 7, 2009
Brian Orelli |
Thanks for Nothing, CMS Insurers like Humana, Coventry Health Care, and UnitedHealth Group are going to have to raise the prices of their Medicare Advantage plans to keep their margins at a reasonable level. |
The Motley Fool
February 20, 2009
Brian Orelli |
The Stimulus Bill Could Bite These Companies Companies that have laid off employees will be responsible for tracking down those former employees and letting them know that they're eligible for a new COBRA discount. |
The Motley Fool
December 6, 2007
Selena Maranjian |
Your Drugs Are in the Mail Order medications online and save. According to a study by the Lewin Group, mail-order pharmacies, such as Medco and Express Scripts, can save you as much as 10% overall. |
The Motley Fool
December 19, 2006
Matthew Crews |
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. |
The Motley Fool
May 6, 2008
Brian Orelli |
Free Drugs Free over-the-counter drugs are a win-win for health insurers and their members. |
The Motley Fool
November 9, 2005
Brian Gorman |
Caremark's Room to Grow Fickle investors may fret about near-term growth, but the pharmacy benefit manager is prepared for the long haul. Investors looking for a long-term holding may want to mark a place in their portfolio for this company. |
Managed Care
October 2003 |
Medco Health Solutions tops consumer survey The 2003 WilsonRx Survey reports that patients have identified Medco Health Solutions as the top pharmacy benefit manager for the third year in a row. |
The Motley Fool
December 19, 2006
Brian Gorman |
Novartis Cuts in Line at the Drugstore Consolidation in pharmacy benefits management may leave Novartis most resistant to pricing pressure. Investors, take note. |
The Motley Fool
June 10, 2010
Claire Stephanic |
CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers. |
The Motley Fool
March 7, 2008
Brian Orelli |
Insurers' Tarnished Reputations Shine Find out which ones rank lowest and why it doesn't matter. |
Managed Care
August 2007 |
Managed Care Outlook Specialty drugs increasingly used to treat chronic conditions. |
The Motley Fool
February 22, 2005
Brian Gorman |
Novartis Embraces Generics The company is taking a different path from its branded pharmaceutical peers. The company's strategy may make its stock worth a closer look. |
The Motley Fool
April 17, 2008
Brian Orelli |
FDA and Health Insurers Take On Drugmakers The FDA is teaming up with health insurer WellPoint to use the company's vast database of 35 million members' medical records to try find drugs' side effects. |
The Motley Fool
September 21, 2006
Vitaliy Katsenelson |
Don't Hit the Panic Button Just Yet Wall Street plays the overreacting game; Walgreen and CVS suffer. These stocks have big tailwinds behind them. |
The Motley Fool
October 29, 2009
Brian Orelli |
Expressing Itself Nicely A nice quarter for Express Scripts. |
The Motley Fool
February 23, 2009
Brian Bauer |
4 Stocks for Scaredy-Cats Cautious investors -- let's call them the scaredy-cats -- think the economy might take longer to recover than many expect. Here are four stocks for them: Johnson & Johnson... PepsiCo... McDonald's... CVS Caremark... |
The Motley Fool
April 25, 2007
Billy Fisher |
A Healthy Diet of Profits at WellPoint For the nation's largest health insurer, the waters aren't always going to be smooth for sailing. Investors, take note. |
The Motley Fool
October 6, 2011
Dan Caplinger |
Has Medco Health Solutions Become the Perfect Stock? A lot has happened in the pharmacy benefits management space since we looked at Medco last year. |
BusinessWeek
March 7, 2005
Amy Barrett |
A Drug Company On Growth Hormones By adding Accredo to its portfolio, Medco gains a strong presence in the area of specialty drugs. Investors sent Medco's stock down slightly on news of the deal. But they give company chief David B. Snow Jr. credit for putting Medco in a position to capitalize on new opportunities. |
The Motley Fool
March 11, 2008
Brian Orelli |
WellPoint Is Not Well WellPoint lowers guidance on its earnings per share from 15% in 2008 to only 4% to 8%. |
The Motley Fool
April 30, 2008
Brian Orelli |
Medco's Far-From-Generic Quarter Pharmacy benefit manager Medco Health Solutions benefits from new generic drugs. |
The Motley Fool
November 5, 2007
Billy Fisher |
Still Fit at Cigna Earnings growth continues for the insurer, complemented by a big buyback in the third quarter. |
The Motley Fool
March 30, 2009
Brian Orelli |
Change the Game? Change the Rules! There are ways for investors to get around Obama's plan to lower health care costs. Investing in drug companies in this time of "change" doesn't have to be scary. You've just got to find rule breaker-type drugmakers, because playing by the rules isn't going to cut it anymore. |
The Motley Fool
February 4, 2008
Timothy M. Otte |
CVS Has Major Mo' Fourth-quarter results cap a stellar year for the drugstore retailer. |
Managed Care
January 2007
Martin Sipkoff |
Employers Want Plans & PBMs To Push Hard for Generics Health insurers' aggressive stand on members' use of generic drugs can attract new clients, but does it interfere with the physician-patient relationship? |
The Motley Fool
March 10, 2009
Devon Rackle |
Almost Family: Results, Shmesults Cuts in Obama's budget proposal overshadow an otherwise solid quarter for the home health care company. |
The Motley Fool
August 1, 2006
Selena Maranjian |
Prescription for Prescription Bargains Did you know that your medications might be cheaper around the corner? Another way to offset your net expenses on medications is to make some money on drugs -- by investing in drug-related firms. |
The Motley Fool
October 28, 2010 |
Our Top Stock Idea Our investing community's latest prime pick -- Medco Health Solutions. |
